Business Context and Reporting Period
Company: Sharps Technology, Inc. (STSS)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2025
Business Overview: The Company has fundamentally pivoted from a medical device manufacturer and distributor of syringes to a digital asset treasury company. In August 2025, it adopted a strategy to accumulate Solana (SOL) as its primary treasury reserve asset. Concurrently, the Company settled litigation regarding its Hungarian subsidiary, transferring those assets and classifying the manufacturing operations as discontinued.
Key Financial Metrics
| Metric | 2025 | 2024 |
|---|---|---|
| Net Revenue (Medical Devices) | $204,120 | $0 |
| Staking Revenue (Digital Assets) | $6,805,009 | $0 |
| Net Loss | $(282,502,126) | $(9,296,201) |
| Unrealized Loss on Digital Assets | $(152,952,163) | $0 |
| Stock-Based Compensation | $107,468,174 | $520,830 |
| Cash and Cash Equivalents | $10,382,745 | $754,802 |
| Digital Assets (Fair Value) | $250,111,125 | $0 |
| Working Capital | $14,187,484 | $(2,011,679) |
Material Changes vs. Prior Period
- Strategic Pivot: The Company ceased R&D and manufacturing of syringes in October 2025, shifting focus entirely to a SOL treasury strategy. This resulted in the classification of the Hungarian subsidiary as a discontinued operation.
- Capital Raise: In August 2025, the Company completed a PIPE offering raising approximately $411 million in gross proceeds (cash, stablecoins, and in-kind SOL). Net proceeds were approximately $403 million.
- Expense Surge: Operating expenses increased significantly to $276.1 million in 2025 from $5.6 million in 2024. This was driven by a $101.3 million non-cash charge for warrants issued to a related-party strategic advisor and $152.9 million in unrealized losses on SOL holdings due to market price fluctuations.
- Liquidity Improvement: Cash balances increased from $0.75 million to $10.4 million, and working capital turned positive, primarily due to the August 2025 capital raise.
Guidance, Outlook, and Risks
Outlook and Strategy: Management intends to maintain a long-term exposure to SOL, utilizing staking to generate yield (targeting up to 95% of holdings staked). The Company plans to use proceeds from SOL sales to fund strategic acquisitions, share repurchases, or operational expansion. A $100 million share repurchase program was approved in October 2025.
Key Risks and Contingencies:
- Asset Volatility: The Company's financial results are highly sensitive to the market price of SOL. A 10% change in SOL price could impact pre-tax income by approximately $25 million.
- Related Party Transactions: The Company entered into a 20-year consulting agreement with Sol Edge Limited (controlled by the brother of the Chief Investment Officer) involving an upfront $10 million fee and ongoing percentage-based fees. Additionally, $101.3 million in warrants were issued to a related-party strategic advisor.
- Regulatory Uncertainty: Risks include potential reclassification of SOL as a security, which could subject the Company to the Investment Company Act of 1940, and evolving regulations regarding digital asset custody and staking.
- Custody and Cybersecurity: The Company relies on third-party custodians (BitGo, Anchorage, Coinbase). Risks include custodian insolvency, smart contract vulnerabilities, and potential loss of private keys.
Investor Verification Checklist
- Related Party Fees: Verify the terms and ongoing costs of the 20-year consulting agreement with Sol Edge Limited and the valuation of warrants issued to Sol Markets.
- SOL Valuation: Confirm the current fair value of the ~2.08 million SOL holdings and the specific discount applied to "locked" SOL tokens (currently 10%).
- Custody Arrangements: Review the specific insurance coverage limits and segregation of assets provided by BitGo, Anchorage, and Coinbase.
- Discontinued Operations: Confirm the final settlement of the Hungarian subsidiary transfer and ensure no residual liabilities remain.
- Share Repurchases: Monitor the execution of the $100 million repurchase program and its impact on outstanding share count.